7 Results
Guidelines and Advice
Status: In-Review
ID: 1-21
ID: 1-21
Sep 2014
Guidelines and Advice
Status: In-Review
ID: 17-4
Version: 2
ID: 17-4
Version: 2
Nov 2016
Guidelines and Advice
Status: Current
ID: 17-8
ID: 17-8
Jan 2014
Guidelines and Advice
Status: Current
ID: GL-C50-14
ID: GL-C50-14
Mar 2014
Statistical Reports
Jun 2016
Cancer facts
Drug
Other Name(s): Sandostatin® (multiple brands available)
, Sandostatin® LAR™ (Novartis)
Aug 2016